|

D20054;LITT for Spine Tumors

RECRUITINGN/ASponsored by Dartmouth-Hitchcock Medical Center
Actively Recruiting
PhaseN/A
SponsorDartmouth-Hitchcock Medical Center
Started2024-05-16
Est. completion2029-06-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06548061

Summary

The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Histology confirmed spinal tumor involving the T2-T12 spine segments.
2. Indication for spine stereotactic radiosurgery or palliative intervention.
3. Normal neurologic exam at the time of presentation (Frankel grade E).

Exclusion Criteria:

1. Contraindication to MRI
2. ANY neurologic deficit
3. Tumor spanning more than 3 consecutive vertebral segments
4. Contraindication to general anesthesia
5. Pregnancy

Conditions2

CancerSpinal Metastases

Locations1 site

Dartmouth Health
Lebanon, New Hampshire, 03766
Lauren Sinks, MPH(603) 653-9021lauren.j.sinks@hitchcock.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.